Clarivate

OCTOBER 31, 2023

These years witnessed significant troughs in pharma financing, a drop in the capital markets, and an IPO window that remained firmly shut. Big pharma is still keen to access good technology, science, and assets, in many cases to plug a patent-expiry-shaped hole in their coffers. In short, the biotech bubble had burst. Pfizer’s $11.6

Pharma 52

Pharma Biopharma Marketing Healthcare 52

PM360

APRIL 22, 2024

The Unique Challenges of Patient/Pharma Interaction Patient engagement has become a critical component of medical marketing. With healthcare professionals becoming less accessible to biopharma reps, the emphasis has shifted toward patient empowerment.

Patients 52

Patients Biopharma Ethics Marketing 52

PM360

MAY 10, 2024

May 9, 2024 /PRNewswire/ — VUE Health, a Boston-based healthcare advertising agency, has hired Zara Baker as Chief Digital Innovation Officer. Before that, she was the head of omnichannel strategy at Ionis Pharma and held senior digital roles at various healthcare and biopharma companies. SOURCE VUE Health

Healthcare 52

Healthcare Healthcare Biopharma Engineering 52

PM360

SEPTEMBER 30, 2024

Sustainable Tech’s Positive Effect on Pharma Funding Recent innovations, including rapid advancements in AI-powered technologies and GLP-1s, have significantly impacted the investment climate and consolidated funding to a smaller number of organizations in the last eight months.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

Clarivate

SEPTEMBER 11, 2024

Though there is no cure for the disease, people with Alzheimer’s can receive personalized, multimodal care and support to delay deterioration of their functional status and quality of life and alleviate the burden imposed on their care partners (Emblad, 2021; Bayly, 2021; Xiang, 2024). Food and Drug Administration, 2023 and 2024).

Food and Drug Administration 59

Food and Drug Administration Pharmacology Food FDA 59

PM360

MAY 21, 2024

In this issue, we take a closer look at the evolution of the Smart TV and the increase of streaming services and how they can benefit the pharma industry. Biopharma marketers are following their audiences and investment in this channel continues to increase. According to Nielsen, streaming accounts for 38% of viewership hours.

Media 105

Media Healthcare Healthcare Marketing 105

PM360

OCTOBER 8, 2024

The high-profile appointment follows the merger of Bioclinica DSS, MyMeds&Me and Commonwealth Informatics under the Qinecsa brand two years ago, and the recent addition of Insife to the group in Q1 2024. The business is supported by investment from Stanley Capital Partners.

Leads 52

Leads Safety Biopharma Management 52

PM360

AUGUST 26, 2024

Fortune 500s or Start-Ups; what are the opportunities and challenges for top school business graduates to consider for the Healthcare/Pharma/Biotech vertical? A: (Galeota) MIT Sloan’s and all MIT students should consider the tremendous career opportunities that the Healthcare/Pharma/Biotech vertical offers.

Distribution 52

Distribution Biopharma Healthcare Healthcare 52

Clarivate

MAY 14, 2024

With only two3 GLP-1 drugs currently approved for weight loss—Huadong Medicine’s version of daily dosed liraglutide and thrice-a-day dosed beinaglutide from Benamae Pharma—the gap is substantial and leaves a solid market opportunity for weight loss drugs. What’s leading to the boom in development of semaglutide biosimilars?

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

PM360

APRIL 22, 2024

In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience.

Education 59

Education Physicians Healthcare Healthcare 59

Clarivate

SEPTEMBER 5, 2024

This blog summarizes a portion of the data collected, which was previously shared in a poster presented at the May 2024 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference (Read the poster ).

Insurance 52

Insurance Marketing Manufacturing Prescription 52

European Pharmaceutical Review

OCTOBER 8, 2024

CPHI Milan, the premier international pharmaceutical event, will be held from 8 to 10 October 2024 at Fiera Milano, Italy. Conference agenda highlights CPHI Milan will present a comprehensive conference agenda on topics such as sustainability and pharma, next generation mRNA vaccines, European regulation, biomanufacturing, and more.

Pharma 52

Pharma Manufacturing Pharmaceutical Management 52

Clarivate

DECEMBER 14, 2023

Here are a few trends in life sciences and healthcare our analysts are keeping an eye on – and what they expect to see in 2024: Move over, oncology – metabolic drugs are the new hotness: The successful launches of Novo Nordisk’s Wegovy® and Eli Lilly’s Mounjaro® represent a revolutionary pharmacological breakthrough of rare proportions.

Pharma 111

Pharma Government Pharmacology Healthcare 111

Clarivate

MAY 8, 2024

A glance at the 2023 and early 2024 life science dealmaking environment shows fewer, but higher-value, transactions. Other partnerships of note include one for a couple of Shanghai-based Elpiscience Biopharma Ltd’s preclinical bispecific antibody assets, licensed by Tokyo-based Astellas Pharma Inc, with the option to license two more.

Pharma 59

Pharma Biopharma Prospecting Competition 59

PM360

JUNE 24, 2024

But the role of AI in healthcare will go beyond this. healthcare, with its 17% share of GDP, is “the most disruptable industry in the world,” and “the first big carcass that AI is going to start to feed on.” Efficiencies with AI As for healthcare marketers, there are a number of ways AI is starting to optimize our workflows.

Healthcare 52

Healthcare Healthcare Patients Side effects 52

Clarivate

DECEMBER 19, 2022

Expansion opportunities for 2024 are relatively obvious, since the partners could expand to the three states with Walmart Health locations (Arkansas, Illinois, Texas ). Clarivate Associate Healthcare Research & Data Analysts Anubhav Sharma and Prashanth Jain contributed to this report. payer marketplace, please visit us here.

Competition 52

Competition Retail Insurance Marketing 52

Clarivate

AUGUST 7, 2024

The three largest pharmacy benefit managers (PBMs) in the United States—Express Scripts, OptumRx and CVS Caremark—control more than 80% of the market share (per Clarivate data, as of January 2024). Click here to learn more about how Clarivate helps biopharma companies navigate market access across global markets.

Retail 59

Retail Marketing Competition Biopharma 59

European Pharmaceutical Review

APRIL 30, 2024

What are the top three trends that you are seeing in the biopharma manufacturing space? Let’s talk about continuous biopharma manufacturing. Speaking of your biopharma clients, what are you hearing about their main priorities? Sticking to the cell and gene therapy space, what’s your main prediction for 2024?

Manufacturing 97

Manufacturing Food and Drug Administration Biopharma Marketing 97

Clarivate

MAY 13, 2024

According to Clarivate’s latest enrollment data, as of January 2024, Medicaid enrollment had plummeted by nearly 9 million compared to six months prior. For 2024, 18% of enrollees were new to exchange coverage, according to the Centers for Medicare and Medicaid Services. million between January 2023 and January 2024. to about 2.5

Insurance 52

Insurance Marketing Healthcare Healthcare 52

PM360

OCTOBER 18, 2024

Given that you have led big pharma (J&J) and smaller firms (Theravance and now FogPharma), what are the career prospects and trajectory for mid-career / newly graduating students wanting to enter this vertical? What would be your advice for prospective professionals seeking a career in big pharma versus smaller firms, including startups?

Medicine 52

Medicine Education Prospecting Networking 52

PM360

JUNE 24, 2024

Yet, reaching and engaging such niche patient populations and the healthcare professionals (HCPs) who service them can be a challenge. How many touchpoints does the patient have with the healthcare system and which stakeholders do they interact with the most? It all starts with deeply understanding the patient journey.

Patients 118

Patients Education Healthcare Healthcare 118

PM360

AUGUST 7, 2024

Whether you’re a social media manager aiming to enhance engagement, a medical affairs professional measuring the impact of healthcare initiatives, or a marketer refining campaign effectiveness, it is important to understand how to create the best possible outcome for your campaigns and programs.

Media 52

Media Education Physicians Marketing 52

PM360

OCTOBER 22, 2024

DANNY SIGURDSON CEO and Founder Courier Health To effectively engage patients and prescribers to improve overall adherence to prescribed medication regimens, biopharma companies first need the visibility and full context of where a patient stands in their treatment journey. Support healthcare providers in a real and personal way.

Education 52

Education Side effects Medical Patients 52

Clarivate

OCTOBER 7, 2024

Online] Available at: [link] [Accessed 1 10 2024]. The need for considerable research and funding for developing and validating alternative methods may also be an issue (Nuwer, 2022; Anon., If you want to learn more about this solution, please visit Cortellis Drug Discovery Intelligence Platform | Clarivate or contact us. Works cited Anon.,

Food and Drug Administration 52

Food and Drug Administration Pharmacology Food Engineering 52

Clarivate

AUGUST 20, 2024

Announced on August 15, 2024, this first batch of Maximum Fair Prices (MFPs) were mandated by the Inflation Reduction Act of 2022 , which allowed CMS to negotiate what it describes as the maximum fair price for therapies representing the greatest cost to Medicare.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

Pharmaceutical Technology

JANUARY 25, 2023

In December 2022, AEON Biopharma, a biopharmaceutical company, announced its plans to go public through a merger with the SPAC Priveterra Acquisition Corp. In such times, experts expect partnerships between biotechs and big pharma, like the Anima Biotech/AbbVie deal announced earlier this month , to become even more popular.

Marketing 69

Marketing Biopharma Pharma Competition 69

Clarivate

OCTOBER 17, 2024

Healthcare delivery has not been the hottest topic on the campaign trail this election season, despite sharp policy differences between the candidates and parties. Congressional Democrats introduced legislation to make the subsidies permanent in September 2024, but the legislation has no chance of passage so close to the election.

Healthcare 52

Healthcare Healthcare Government Insurance 52